BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23723449)

  • 1. The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation.
    Smith BW; Rozelle SS; Leung A; Ubellacker J; Parks A; Nah SK; French D; Gadue P; Monti S; Chui DH; Steinberg MH; Frelinger AL; Michelson AD; Theberge R; McComb ME; Costello CE; Kotton DN; Mostoslavsky G; Sherr DH; Murphy GJ
    Blood; 2013 Jul; 122(3):376-85. PubMed ID: 23723449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
    Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
    Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical modeling reveals differential effects of erythropoietin on proliferation and lineage commitment of human hematopoietic progenitors in early erythroid culture.
    Ward D; Carter D; Homer M; Marucci L; Gampel A
    Haematologica; 2016 Mar; 101(3):286-96. PubMed ID: 26589912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the role of the aryl hydrocarbon receptor to regulate early hematopoietic development.
    Angelos MG; Kaufman DS
    Curr Opin Hematol; 2018 Jul; 25(4):273-278. PubMed ID: 29697485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEIS1 regulates early erythroid and megakaryocytic cell fate.
    Zeddies S; Jansen SB; di Summa F; Geerts D; Zwaginga JJ; van der Schoot CE; von Lindern M; Thijssen-Timmer DC
    Haematologica; 2014 Oct; 99(10):1555-64. PubMed ID: 25107888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.
    Boitano AE; Wang J; Romeo R; Bouchez LC; Parker AE; Sutton SE; Walker JR; Flaveny CA; Perdew GH; Denison MS; Schultz PG; Cooke MP
    Science; 2010 Sep; 329(5997):1345-8. PubMed ID: 20688981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch and Aryl Hydrocarbon Receptor Signaling Impact Definitive Hematopoiesis from Human Pluripotent Stem Cells.
    Leung A; Zulick E; Skvir N; Vanuytsel K; Morrison TA; Naing ZH; Wang Z; Dai Y; Chui DHK; Steinberg MH; Sherr DH; Murphy GJ
    Stem Cells; 2018 Jul; 36(7):1004-1019. PubMed ID: 29569827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro model of human hematopoiesis identifies a regulatory role for the aryl hydrocarbon receptor.
    Khan DMIO; Karmaus PWF; Bach A; Crawford RB; Kaminski NE
    Blood Adv; 2023 Oct; 7(20):6253-6265. PubMed ID: 37477592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.
    Platzer B; Richter S; Kneidinger D; Waltenberger D; Woisetschläger M; Strobl H
    J Immunol; 2009 Jul; 183(1):66-74. PubMed ID: 19535631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells.
    Angelos MG; Ruh PN; Webber BR; Blum RH; Ryan CD; Bendzick L; Shim S; Yingst AM; Tufa DM; Verneris MR; Kaufman DS
    Blood; 2017 Jun; 129(26):3428-3439. PubMed ID: 28533309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative Effect of Erythropoietin and TGF-β Inhibition on Erythroid Development in Human Pluripotent Stem Cells.
    Xie Y; Bai H; Liu Y; Hoyle DL; Cheng T; Wang ZZ
    J Cell Biochem; 2015 Dec; 116(12):2735-43. PubMed ID: 26012423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocyte lineage development is controlled by modulation of protein acetylation.
    Bartels M; Govers A; Polak R; Vervoort S; van Boxtel R; Pals C; Bierings M; van Solinge W; Egberts T; Nieuwenhuis E; Mokry M; Coffer PJ
    PLoS One; 2018; 13(4):e0196400. PubMed ID: 29698469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Aryl Hydrocarbon Receptor Modulates Murine Hematopoietic Stem Cell Homeostasis and Influences Lineage-Biased Stem and Progenitor Cells.
    Vaughan KL; Franchini AM; Kern HG; Lawrence BP
    Stem Cells Dev; 2021 Oct; 30(19):970-980. PubMed ID: 34428990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor.
    García P; Frampton J
    Dev Cell; 2008 Jun; 14(6):815-6. PubMed ID: 18539110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of Human Megakaryocyte-Lineage Progeny via Aryl Hydrocarbon Receptor Antagonism with CH223191.
    Kim D; Shin DY; Liu J; Jeong NR; Koh Y; Hong J; Huang X; Broxmeyer HE; Yoon SS
    Stem Cell Rev Rep; 2022 Dec; 18(8):2982-2994. PubMed ID: 35687264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]anthracene-induced pre-B lymphocyte apoptosis.
    Mann KK; Matulka RA; Hahn ME; Trombino AF; Lawrence BP; Kerkvliet NI; Sherr DH
    Toxicol Appl Pharmacol; 1999 Nov; 161(1):10-22. PubMed ID: 10558919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem and progenitor cell activation during chronic dermatitis provoked by constitutively active aryl-hydrocarbon receptor driven by Keratin 14 promoter.
    Murakami S; Yamamoto M; Motohashi H
    Toxicol Sci; 2014 Mar; 138(1):47-58. PubMed ID: 24287212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
    Lu J; Guo S; Ebert BL; Zhang H; Peng X; Bosco J; Pretz J; Schlanger R; Wang JY; Mak RH; Dombkowski DM; Preffer FI; Scadden DT; Golub TR
    Dev Cell; 2008 Jun; 14(6):843-53. PubMed ID: 18539114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF.
    Bianchi E; Bulgarelli J; Ruberti S; Rontauroli S; Sacchi G; Norfo R; Pennucci V; Zini R; Salati S; Prudente Z; Ferrari S; Manfredini R
    Cell Death Differ; 2015 Dec; 22(12):1906-21. PubMed ID: 25857263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.